BHG (replaced AG as diagnostic criteria in latest DKA/HHS guidelines) 3.3 (mimimum mEq/L K should be prior to initiated insulin infusion) 50 (average mg/dL drop in BGL per 1 unit rapid acting insulin) Infection (driver of DKA outside of non compliance and new diagnosis) Cerebral Edema (complication of rapidly decreasing BGL in HHS patients (primarily in the young) Basal (another term for long acting insulin) 250 (BGL cut off to start adding dextrose to fluids in DKA) 0.5 (units/kg/day; recommend starting dose for new start insulin) <6.9 (pH cut off for routine administration of sodium bicarb) Octerotide (medication that be used in SU/insulin overdose) 20 (# mEq of K that should be added to each liter with concurrent insulin infusion) Polydipsia, polyphagia, polyuria (hallmark symptoms of uncontrolled/undiagnosed DM) 1 (units/mL; standard concentration of IV insulin infusion) 0.1 (units/kg/hr for non glucommander DKA/HHS) 600 (BGL level with HHS glucose diagnostic criteria/max MHS glucommander reading) 126 (Fasting BGL for DM diagnosis) Fluids (most important initial treatment in hyperglycemic emergencies) IV (should only be used for patients with DKA/HHS/Hyperkalemia) LR (fluid choiced for faster resolution of acidosis in DKA) SQUID (protocol/trial that supported the addition of SQ insulin in the magangement of mild DKA) Euglycemic (Type of DKA that can be an adverse event with use of SGLT2s) <7.3 (pH criteria for DKA diagnosis) Kussmals (types of respirations associated with DKA) 6.5 (A1C DM diagnostic criteria) Lactic acidosis (possible complication of hallmark DM oral therapy) 320 (Total serum omolarity cut off for HHS) Awiqli (newest FDA approved insulin) 300 (BGL cut off to start adding dextrose to fluids in HHS) BHG (replaced AG as diagnostic criteria in latest DKA/HHS guidelines) 3.3 (mimimum mEq/L K should be prior to initiated insulin infusion) 50 (average mg/dL drop in BGL per 1 unit rapid acting insulin) Infection (driver of DKA outside of non compliance and new diagnosis) Cerebral Edema (complication of rapidly decreasing BGL in HHS patients (primarily in the young) Basal (another term for long acting insulin) 250 (BGL cut off to start adding dextrose to fluids in DKA) 0.5 (units/kg/day; recommend starting dose for new start insulin) <6.9 (pH cut off for routine administration of sodium bicarb) Octerotide (medication that be used in SU/insulin overdose) 20 (# mEq of K that should be added to each liter with concurrent insulin infusion) Polydipsia, polyphagia, polyuria (hallmark symptoms of uncontrolled/undiagnosed DM) 1 (units/mL; standard concentration of IV insulin infusion) 0.1 (units/kg/hr for non glucommander DKA/HHS) 600 (BGL level with HHS glucose diagnostic criteria/max MHS glucommander reading) 126 (Fasting BGL for DM diagnosis) Fluids (most important initial treatment in hyperglycemic emergencies) IV (should only be used for patients with DKA/HHS/Hyperkalemia) LR (fluid choiced for faster resolution of acidosis in DKA) SQUID (protocol/trial that supported the addition of SQ insulin in the magangement of mild DKA) Euglycemic (Type of DKA that can be an adverse event with use of SGLT2s) <7.3 (pH criteria for DKA diagnosis) Kussmals (types of respirations associated with DKA) 6.5 (A1C DM diagnostic criteria) Lactic acidosis (possible complication of hallmark DM oral therapy) 320 (Total serum omolarity cut off for HHS) Awiqli (newest FDA approved insulin) 300 (BGL cut off to start adding dextrose to fluids in HHS)
(Print)
BHG (replaced AG as diagnostic criteria in latest DKA/HHS guidelines)
3.3 (mimimum mEq/L K should be prior to initiated insulin infusion)
50 (average mg/dL drop in BGL per 1 unit rapid acting insulin)
Infection (driver of DKA outside of non compliance and new diagnosis)
Cerebral Edema (complication of rapidly decreasing BGL in HHS patients (primarily in the young)
Basal (another term for long acting insulin)
250 (BGL cut off to start adding dextrose to fluids in DKA)
0.5 (units/kg/day; recommend starting dose for new start insulin)
<6.9 (pH cut off for routine administration of sodium bicarb)
Octerotide (medication that be used in SU/insulin overdose)
20 (# mEq of K that should be added to each liter with concurrent insulin infusion)
Polydipsia, polyphagia, polyuria (hallmark symptoms of uncontrolled/undiagnosed DM)
1 (units/mL; standard concentration of IV insulin infusion)
0.1 (units/kg/hr for non glucommander DKA/HHS)
600 (BGL level with HHS glucose diagnostic criteria/max MHS glucommander reading)
126 (Fasting BGL for DM diagnosis)
Fluids (most important initial treatment in hyperglycemic emergencies)
IV (should only be used for patients with DKA/HHS/Hyperkalemia)
LR (fluid choiced for faster resolution of acidosis in DKA)
SQUID (protocol/trial that supported the addition of SQ insulin in the magangement of mild DKA)
Euglycemic (Type of DKA that can be an adverse event with use of SGLT2s)
<7.3 (pH criteria for DKA diagnosis)
Kussmals (types of respirations associated with DKA)
6.5 (A1C DM diagnostic criteria)
Lactic acidosis (possible complication of hallmark DM oral therapy)
320 (Total serum omolarity cut off for HHS)
Awiqli (newest FDA approved insulin)
300 (BGL cut off to start adding dextrose to fluids in HHS)
